<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Dicerna Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Dicerna Pharmaceuticals, Inc.

    Dicerna is a biopharmaceutical company focused on the discovery and development of innovative treatments for rare diseases, chronic liver diseases, cardiovascular disease, and viral liver infectious diseases. The Company is using its proprietary GalXC RNAi technology platform to build a broad pipeline in these therapeutic areas. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $188,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Douglas M. Fambrough, III, Ph.D.
    • FOUNDED
      2007
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Insitu Biologics, Inc

    Insitu Biologics, Inc

    InSitu Biologics is an emerging biotech company focusing on development of AnestaG...

    InSitu Biologics is an emerging biotech company...

    Amount Raised:    $2,000,000.00
    Fundraising Status:    EC
    Filing Type:    RA
    BiondVax Pharmaceuticals Ltd.

    BiondVax Pharmaceuticals Ltd.

    BiondVax is an innovative biopharmaceutical company developing a universal flu vac...

    BiondVax is an innovative biopharmaceutical com...

    Filing Type:    PU
    TransMedics Group, Inc.

    TransMedics Group, Inc.

    TransMedics is a commercial-stage medical technology company transforming organ tr...

    TransMedics is a commercial-stage medical techn...

    Filing Type:    PU
    Innovate Biopharmaceuticals, Inc.

    Innovate Biopharmaceuticals, Inc.

    Innovate is a publicly traded (Nasdaq: INNT) clinical stage biotechnology company ...

    Innovate is a publicly traded (Nasdaq: INNT) cl...

    Filing Type:    PU
    Molecular Templates, Inc.

    Molecular Templates, Inc.

    Molecular Templates is focused on the discovery, development, and commercializatio...

    Molecular Templates is focused on the discovery...

    Filing Type:    PU
    Emerald Health Pharmaceuticals Inc

    Emerald Health Pharmaceuticals Inc

    Emerald Health Pharmaceuticals (EHP) combines decades of life science and drug dev...

    Emerald Health Pharmaceuticals (EHP) combines d...

    Amount Raised:    11.600,000.00
    Fundraising Status:    EC
    Filing Type:    RA
    Mirum Pharmaceuticals, Inc.

    Mirum Pharmaceuticals, Inc.

    Mirum Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused o...

    Mirum Pharmaceuticals Inc. is a clinical-stage ...

    Filing Type:    PU
    Cara Therapeutics, Inc.

    Cara Therapeutics, Inc.

    Cara Therapeutics is a clinical-stage biopharmaceutical company focused on develop...

    Cara Therapeutics is a clinical-stage biopharma...

    Filing Type:    PU
    NGM Biopharmaceuticals, Inc.

    NGM Biopharmaceuticals, Inc.

    We are a clinical stage biopharmaceutical company focused on harnessing powerful b...

    We are a clinical stage biopharmaceutical compa...

    Filing Type:    PU
    Cardiovascular Systems, Inc.

    Cardiovascular Systems, Inc.

    Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device compan...

    Cardiovascular Systems, Inc., based in St. Paul...

    Filing Type:    PU
    Correvio Pharma Corp.

    Correvio Pharma Corp.

    Correvio has two marketed, in-hospital, cardiology products: BRINAVESSÂŽ (vernakal...

    Correvio has two marketed, in-hospital, cardiol...

    Filing Type:    PU
    AtriCure, Inc.

    AtriCure, Inc.

    As a leading provider of innovative technologies for the treatment of Atrial Fibri...

    As a leading provider of innovative technologie...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.